These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38183694)

  • 1. Utility of the Brief Assessment of Cognitive Health (BACH) computerized screening tool in identifying MS-related cognitive impairment.
    Patrick KS; Chakrabati S; Rhoads T; Busch RM; Floden DP; Galioto R
    Mult Scler Relat Disord; 2024 Feb; 82():105398. PubMed ID: 38183694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is computerized screening for processing speed impairment sufficient for identifying MS-related cognitive impairment in a clinical setting?
    Galioto R; Macaron G; Lace JW; Ontaneda D; Rao SM
    Mult Scler Relat Disord; 2021 Sep; 54():103106. PubMed ID: 34217998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring cognitive function by the SDMT across functional domains: Useful but not sufficient.
    Leach JM; Cutter G; Golan D; Doniger G; Zarif M; Bumstead B; Buhse M; Kaczmarek O; Sethi A; Covey T; Penner IK; Wilken J; Gudesblatt M
    Mult Scler Relat Disord; 2022 Apr; 60():103704. PubMed ID: 35259683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
    Charvet LE; Beekman R; Amadiume N; Belman AL; Krupp LB
    J Neurol Sci; 2014 Jun; 341(1-2):79-84. PubMed ID: 24792098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trail Making Test Could Predict Impairment in Cognitive Domains in Patients with Multiple Sclerosis: A Study of Diagnostic Accuracy.
    Kabiri S; Jameie M; Balali P; Adib Moradi S; Sanjari Moghaddam H; Aghamollaii V; Harirchian MH
    Arch Clin Neuropsychol; 2023 Jan; 38(1):37-48. PubMed ID: 35901460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.
    Marstrand L; Østerberg O; Walsted T; Skov AC; Schreiber KI; Sellebjerg F
    Mult Scler Relat Disord; 2020 Jan; 37():101458. PubMed ID: 31683230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated detection of cognitive impairment in clinical practice.
    Busch RM; Hogue O; Postle AF; Floden DP
    J Neurol; 2024 Aug; 271(8):5187-5196. PubMed ID: 38834701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
    Walker LA; Osman L; Berard JA; Rees LM; Freedman MS; MacLean H; Cousineau D
    J Neurol Sci; 2016 Mar; 362():147-52. PubMed ID: 26944137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in the Russian Population.
    Evdoshenko E; Laskova K; Shumilina M; Nekrashevich E; Andreeva M; Neofidov N; Kalinin I; Nikitchenko D; Rogozina A; Kupaeva A; Bulanov I; Bakirtzis C; Grigoriadis N; Khachanova N; Davydovskaya M; Makshakov G
    J Int Neuropsychol Soc; 2022 May; 28(5):503-510. PubMed ID: 34132190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
    Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
    Eur J Neurol; 2014 Sep; 21(9):1219-25, e71-2. PubMed ID: 24850580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a self-administered iPad
    Hechenberger S; Helmlinger B; Tinauer C; Jauk E; Ropele S; Heschl B; Wurth S; Damulina A; Eppinger S; Demjaha R; Khalil M; Enzinger C; Pinter D
    J Neurol; 2024 Jun; 271(6):3268-3278. PubMed ID: 38441609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining cognitive speed and accuracy dysfunction in youth and young adults with pediatric-onset multiple sclerosis using a computerized neurocognitive battery.
    Barlow-Krelina E; Fabri TL; O'Mahony J; Gur RC; Gur RE; De Somma E; Bolongaita L; Dunn CL; Bacchus M; Yeh EA; Marrie RA; Bar-Or A; Banwell BL; Till C
    Neuropsychology; 2021 May; 35(4):388-398. PubMed ID: 34043389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis.
    Ruet A; Deloire MS; Charré-Morin J; Hamel D; Brochet B
    Mult Scler; 2013 Oct; 19(12):1665-72. PubMed ID: 23459569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-administered, artificial intelligence (AI) platform for cognitive assessment in multiple sclerosis (MS).
    Khaligh-Razavi SM; Sadeghi M; Khanbagi M; Kalafatis C; Nabavi SM
    BMC Neurol; 2020 May; 20(1):193. PubMed ID: 32423386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symbol digit modalities test predicts decline of off-road driving ability in Japanese patients with multiple sclerosis.
    Maeta M; Mizuno M; Okubo S; Ogasawara M; Terauchi T; Suzuki M; Akasaka H; Sato Y; Ohi K; Maeda T
    Mult Scler Relat Disord; 2022 Dec; 68():104150. PubMed ID: 36055114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): Validation in Arabic and Lebanese Normative Values.
    Darwish H; Zeinoun P; Farran N; Ghusn H; Yamout B; Khoury SJ
    J Int Neuropsychol Soc; 2022 Jan; 28(1):94-103. PubMed ID: 33563350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between processing speed and verbal and non-verbal new learning and memory in progressive multiple sclerosis.
    Chiaravalloti ND; DeLuca J; Salter A; Amato MP; Brichetto G; Chataway J; Dalgas U; Farrell R; Feys P; Filippi M; Freeman J; Inglese M; Meza C; Moore NB; Motl RW; Rocca MA; Sandroff BM; Cutter G; Feinstein A
    Mult Scler; 2022 Oct; 28(11):1783-1792. PubMed ID: 35531965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of a computerized version of the symbol digit modalities test in multiple sclerosis.
    Akbar N; Honarmand K; Kou N; Feinstein A
    J Neurol; 2011 Mar; 258(3):373-9. PubMed ID: 20924594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.